文献速递真菌感染

真菌特异性影像放射性示踪剂的研发:过去、现在与未来

Radiotracer Development for Fungal-Specific Imaging: Past, Present, and Future.
PubMed 文献 · J Infect Dis · 2023-01-01

本综述概述了真菌特异性影像放射性示踪剂的研发进展。侵袭性真菌感染因免疫受损患者增多而成为公共卫生重大挑战,传统CT和MRI在需要快速、无创、特异性诊断时往往不足。综述总结了放射性标记肽、抗真菌药物、铁载体、真菌特异性抗体和糖类等示踪剂的优缺点,并讨论了真菌特异性影像的未来前景。

要点

  • 侵袭性真菌感染发病率与死亡率高,传统CT和MRI在快速特异性诊断方面存在不足
  • 分子影像尤其是核医学技术旨在开发可在临床前模型测试并最终转化至人体的真菌特异性示踪剂
  • 已研发的示踪剂包括放射性标记肽、抗真菌药物、铁载体、真菌特异性抗体和糖类

核心结论

  • 真菌特异性影像放射性示踪剂的研发已积累多类候选分子,本综述旨在概述现有示踪剂的优缺点并讨论未来前景。

研究设计与样本

  • 本文为综述,未报告检索数据库、检索时间范围或纳入文献数量。

主要发现

  • 已研发并测试的真菌特异性示踪剂包括放射性标记肽、抗真菌药物、铁载体、真菌特异性抗体和糖类。
  • 传统影像手段如计算机断层扫描和磁共振成像在需要快速、无创且特异的真菌感染诊断时往往不足。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Invasive fungal infections have become a major challenge for public health, mainly due to the growing numbers of immunocompromised patients, with high morbidity and mortality. Currently, conventional imaging modalities such as computed tomography and magnetic resonance imaging contribute largely to the noninvasive diagnosis and treatment evaluation of those infections. These techniques, however, often fall short when a fast, noninvasive and specific diagnosis of fungal infection is necessary. Molecular imaging, especially using nuclear medicine-based techniques, aims to develop fungal-specific radiotracers that can be tested in preclinical models and eventually translated to human applications. In the last few decades, multiple radioligands have been developed and tested as potential fungal-specific tracers. These include radiolabeled peptides, antifungal drugs, siderophores, fungal-specific antibodies, and sugars. In this review, we provide an overview of the pros and cons of the available radiotracers. We also address the future prospects of fungal-specific imaging.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lai J, Wang B, Petrik M, et al. Radiotracer Development for Fungal-Specific Imaging: Past, Present, and Future. J Infect Dis. 2023. PMID: 37788500. doi:10.1093/infdis/jiad067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。